1
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
Condition(s):NF1; Low-grade GliomaLast Updated:September 15, 2020Not yet recruiting
Poly ICLC: 111 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
Condition(s):Glioblastoma Multiforme; Glioblastoma, Adult; Glioma of Brain; Glioblastoma Multiforme of BrainLast Updated:January 7, 2020Recruiting
3
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Condition(s):Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin CancersLast Updated:November 13, 2019Recruiting
4
Enhancement by Poly-ICLC During HIV-1 Infection
Condition(s):HIV-1 Infected Adults With Chronic HIV-1 InfectionLast Updated:March 13, 2018Completed
5
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Condition(s):Metastatic Colon Cancer; Solid TumorLast Updated:June 17, 2020Recruiting
6
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
Condition(s):Melanoma; Squamous Cell Carcinoma of the Head and Neck; Squamous Cell Carcinoma of the Skin; Sarcoma of the Skin; Basal Cell Cancer of the Skin; Breast CancerLast Updated:January 23, 2018Terminated
7
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
Condition(s):Solid CancerLast Updated:November 1, 2019Recruiting
8
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Condition(s):Glioma; Malignant Glioma; Astrocytoma, Grade II; Oligodendroglioma; Glioma, Astrocytic; Oligoastrocytoma, MixedLast Updated:June 12, 2020Recruiting
9
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
Condition(s):CNS Tumor, AdultLast Updated:April 20, 2016Completed
10
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:August 13, 2012Completed